(5-(Methoxycarbonyl)-2-methylphenyl)boronic acid, 95.0%, 250mg

(2S,4R)-1-(tert-Butoxycarbonyl)-4-methoxypyrrolidine-2-carboxylic acid, 95%, 250mg

Benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate, 98%, 100mg

GC capillary column ROTI®Cap-1, 50 m, 0.53 mm, 5.00 µm, 1 Piece(s)

Ethyl 2-methyl-4-oxocyclohex-2-enecarboxylate, 95.0%, 10g

METHYL 2-AMINO-3,5-DIFLUOROBENZOATE, 95.0%, 1g

(R)-3-((tert-butoxycarbonyl)amino)-3-cyclopropylpropanoic acid, 97%, 100mg

FANANSERIN, 95%, 10mg

2-Bromotriphenylene>98.0%(GC)5g

methyl 3-[(3-phenylpropyl)amino]butanoate, 95.0%, 2g

(4-Bromophenyl)(4-hydroxyphenyl)methanone, 97%, 5g

Membrane filters cellulose nitrate mixed ester 3 µm, 90 mm, 25 Piece(s)

N-(3-phenylpropyl)cyclopropanamine, 97%, 1g